Amplia Therapeutics (Amplia Therapeutics) Operating Cash Flow per Share : $-0.02 (TTM As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Amplia Therapeutics Operating Cash Flow per Share?

Amplia Therapeutics's operating cash flow per share for the six months ended in Sep. 2023 was $-0.01. Amplia Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 10.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Amplia Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

INNMF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -29.1 Med: 11.6 Max: 54.2
Current: 10.8

During the past 10 years, Amplia Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 54.20% per year. The lowest was -29.10% per year. And the median was 11.60% per year.

INNMF's 3-Year OCF Growth Rate is ranked better than
57.57% of 1242 companies
in the Biotechnology industry
Industry Median: 3.75 vs INNMF: 10.80

Amplia Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Amplia Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplia Therapeutics Operating Cash Flow per Share Chart

Amplia Therapeutics Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.02

Amplia Therapeutics Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

Competitive Comparison of Amplia Therapeutics's Operating Cash Flow per Share

For the Biotechnology subindustry, Amplia Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amplia Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amplia Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Amplia Therapeutics's Price-to-Operating-Cash-Flow falls into.

Amplia Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Amplia Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	-3.531	/	199.584
	=	-0.02

Amplia Therapeutics's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	-2.277	/	199.615
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.02

Amplia Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Amplia Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplia Therapeutics (Amplia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amplia Therapeutics Ltd (OTCPK:INNMF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ATX:Australia

Address

350 Queen Street, Level 17, Melbourne, VIC, AUS, 3000

Website

https://www.ampliatx.com

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Amplia Therapeutics (Amplia Therapeutics) Headlines

From GuruFocus

AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer

By PRNewswire PRNewswire • 05-29-2023

FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US

By PRNewswire • 01-18-2024

AACR OVARIAN CANCER CONFERENCE PRESENTATION

By PRNewswire • 10-09-2023